In the next few days and weeks we’ll see the first wave of reactions from health plans – and unsubsidized Affordable Care Act exchange shoppers, because of premium increases – to President Trump’s decision to cut off immediately the cost-sharing subsidies to health plans participating in the exchanges.
The Trump administration dealt a one-two punch to the Affordable Care Act on Thursday. Trump’s executive order would give Americans the option of buying lower-cost health insurance, but also could usher back the bare-bones insurance options that the Affordable Care Act was designed to eliminate.
In addition, Trump directed the U.S. Department of Health and Human Services to end the cost-sharing reduction payments (CSRs) to health insurers required under the ACA effective immediately. The payments always have been controversial, and the Trump administration, in justifying its action, noted that House Republicans earlier successfully challenged them in court. Continue reading
Proove Biosciences, a genetic testing company in Irvine, Calif., was placed into court-ordered receivership at the end of August for “restructuring and asset sale.” Proove’s founder and former CEO Brian Meshkin has blamed the company’s financial problems on investigative articles that Charles Piller, West Coast editor for Stat, wrote about the company’s lead product over the last several months, according to Pillar’s coverage of the receivership proceedings.
Meshkin, who called Piller’s reporting about Proove “erroneous and damaging.” He claimed that stories were based on false allegations from disgruntled employees, ignoring that Piller also had quoted genetic testing experts skeptical of the scientific claims behind the Proove Opioid Risk test. Proove has marketed the test as a way for doctors to predict a patient’s likelihood of becoming addicted to opioids. Continue reading
AHCJ is excited to announce an offer for significantly discounted access to LexisNexis for association members. The offer, made possible in partnership with the Contently Foundation, a nonprofit organization for investigative reporting, will be of particular interest to AHCJ’s freelance members.
LexisNexis is a vital resource for all types of journalists and writers, but it’s particularly valuable for those covering health care in that it contains some 250 industry publications, including the American Journal of Law & Medicine, The American Journal of Surgery, The Lancet, Biotech Business, Modern Healthcare and Occupational Health. Continue reading
Whatever actions Congress and the Trump administration ultimately take to repeal and replace the Affordable Care Act, or in the short term attempt to weaken it, we already know their efforts will affect how many Americans have health insurance. The question now is how much of an effect their efforts will have.
We have sources that can provide a baseline for discussion, such as the National Center for Health Statistics’ (NCHS) National Health Interview Survey (NHIS) and the Gallup Sharecare Well-Being Index. Both resources base their data on surveys and are regularly updated. Continue reading